Biotech 2003

Fusing Science, Technology, and Business Leadership

Speakers

Some of the industry's top experts spoke at Biotech 2003.

   Keynote Speakers

   Featured Speakers

Mary C. Tanner
Senior Managing Director, Investment Banking/Healthcare Group
Bear Stearns & Co., Inc.

A 24-year veteran of the health care and consumer products industry, Mary C. Tanner has gained a consummate knowledge of the pharmaceutical and biotechnology industries. Through her extensive experiences with numerous initial public offerings, financings, mergers, acquisitions, and divestitures, she has effected more than 500 transactions with a total disclosed value of $100+ billion. Throughout her extensive career, Tanner has developed expertise in biotechnology, consumer self-medication, the ethical pharmaceutical industry, and the cosmetics and consumer medicine industries.

Since joining Bear Stearns in 2001, Tanner has concentrated on working with large pharmaceutical and biotech companies. Prior to her work with Bear Stearns, Tanner spearheaded large pharmaceutical transactions as managing director and head of the healthcare practice at Lehman Brothers. In addition to her well-known work with large companies, Ms. Tanner specializes in transactions between large and small companies, including corporate partnering and minority investments.

G. Steven Burrill President Burrill & Co. G. Steven Burrill has been very involved in the growth and prosperity of the biotechnology industry for 35 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained promoters.

Mr. Burrill currently serves as Board Chairman for Paradigm Genetics (NASDAQ: PDGM) and Pyxis Genomics and as a Board member of DepoMed (AMEX: DMI), Galapagos Genomics, Inhibitex (observer), Targacept, and Third Wave Technologies (NASDAQ: TWTI). Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide.

Featured speakers include:

• Leslie Alexandre, President and CEO, North Carolina Biotechnology Center
• Frank Armstrong, University Professor of Biochemistry, Emeritus, North Carolina State University
• Scott Beardsley, Managing Director, Health Care Group, USBancorp Piper Jaffray
• Jim Bongiorno, Senior Manager, Ernst & Young LLP
• Bill Bullock, International Business Development Manager for Biotechnology, N.C. Department of Commerce
• John F.A.V. Cecil, President, Biltmore Farms
• John D. Chaffee, Executive Director, Pitt County Development Commission
• Nelson J. Chao, Director, Bone Marrow Transplant Program, Duke University Medical Center
• Mark Crowell, Associate Vice Chancellor for Economic Development and Director of Technology Development, The University of North Carolina at Chapel Hill
• Bill Dean, President, !dealliance
• Clint G. "Skip" Dederick, Jr., Chairman, CEO and President, Merix Bioscience, Inc.
• Dimitri F. Dimitriou, Chief Executive Officer, DyoDelta Biosciences, London, U.K.
• Governor Mike Easley, State of North Carolina
• Roland Johnson, President and CEO, Piedmont Pharmaceuticals, LLC
• Bruce Kaylos, Plant Manager, Wyeth-Lederle Vaccines
• Patrick Kelly, Vice President, State Government Relations, Biotechnology Industry Organization
• Garheng Kong, Principal, Intersouth Partners
• N. Peter Kostopulos, Womble, Carlyle, Sandridge & Rice, PLLC
• Jeff Lane, Federal Government Relations Group, Womble Carlyle Sandridge & Rice
• Russ Lea, Vice President for Research and Sponsored Programs, The University of North Carolina
• Spencer Lemons, Director, Office of Technology Asset Management, Wake Forest University
• Roger J. Lias, Vice President, Business Development & Commercial Operations, KBI BioPharma, Inc.
• Mike Luther, Vice President, Discovery Research, GlaxoSmithKline
• Terry McGuire, Co-founder and Managing General Partner, Polaris Venture Partners
• Michael Murphy, President and CEO, Gentris Corporation
• Gary Pace, Vice President of Corporate Development & Legal Affairs, Gentris Corporation
• Peter M. Pellerito, Higher Education Policy Advisor, Biotechnology Industry Organization
• Noah M. J. Pickus, Director, Institute for Emerging Issues
• Hal Price, General Manager, Biogen Inc.
• Michael Recny, Vice President for Corporate Development, Trimeris, Inc.
• Christy Shaffer, Chief Executive Officer, Inspire Pharmaceuticals, Inc.
• Sam Taylor, Executive Director, NCBIO
• Ed Torres, Principal, Lilly BioVentures
• Marti Van Scott, Director, Office of Technology Transfer, East Carolina University
• Mark S. Wdowik, Executive Director, Office of Technology Transfer, The University of North Carolina at Charlotte
• John Wilbanks, President and CEO, Incellico, Inc.
• Paul Wood, Vice President, Business & Technology Development, North Carolina Biotechnology Center
• Peter F. Young, President and CEO, AlphaVax, Inc.

Conference Co-chairs:
Helga Leftwich, Hutchison & Mason PLLC
Brent Keating, RBC Centura

CED Conferences: